OBJECTIVES Malva sylvestris L. (Malvaceae), an annual plant, has been already commonly used as a medicinal plant in Iran. In the present work, we evaluate some bioactivities of the plant extracts. MATERIALS AND METHODS The aired-dried plant flowers and leaves were extracted by soxhlet apparatus with n-hexane, dichloromethane and methanol. The antimicrobial, cytotoxic, and phytotoxic of the pl...

OBJECTIVES The aim of this study was to evaluate the effects of Malva sylvestris aqueous extract on cutaneous wound healing in BALB/c mice. MATERIALS AND METHODS Twenty seven male BALB/c mice (2.5 months of age) were used. A cut wound (superficial fascia depth) was made locally. The mice were then divided into three groups: the first, second and third groups received topical administration of...

The current study is on the the use of macro-algae as feedstock for biogas production. Three types of macro-algae, Cladophora glomerata (CG), Chara fragilis (CF), and Spirogyra neglecta (SN), were chosen for this research. The experimental studies on biogas production were carried out with these algae in a batch bioreactor. In the bioreactor was maintained 35 ± 1°C temperature. The results show...

There are a total of eight sensory organs in the chick inner ear. Each sensory organ has a distinct structure tailored for its function, and its morphology is well characterized. However, the origin of these sensory organs and the lineage relationships among them are largely unknown. In this report, we show that BMP4 (bone morphogenetic protein), a secreted protein of the TGF-beta gene family, ...

M. sylvestris inhibits C. albicans biofilm formation Journal of Herbmed Pharmacology, Volume 6, Number 2, April 2017 http://www.herbmedpharmacol.com 63 increased expression of drug efflux pump genes and metabolic plasticity provide protection by preventing the penetration of host immune factors and antifungals agents into the extracellular matrix in comparison to planktonic cells (3,6-10). The ...

lesions occurred in up to a third of patients who initially responded to alitretinoin after 24 weeks of follow-up. A recent study reported that a second course of treatment with alitretinoin at a dosage of 30mg/d in patients who relapsed achieved clearance in up to 80% of cases, with good tolerance; this would indicate that this medication could be used for long-term management of chronic hand ...